HUP0303106A2 - Eljárás pravasztatin tisztítására - Google Patents

Eljárás pravasztatin tisztítására

Info

Publication number
HUP0303106A2
HUP0303106A2 HU0303106A HUP0303106A HUP0303106A2 HU P0303106 A2 HUP0303106 A2 HU P0303106A2 HU 0303106 A HU0303106 A HU 0303106A HU P0303106 A HUP0303106 A HU P0303106A HU P0303106 A2 HUP0303106 A2 HU P0303106A2
Authority
HU
Hungary
Prior art keywords
formula
pravastatin
compound
subject
weight
Prior art date
Application number
HU0303106A
Other languages
English (en)
Inventor
Minoru Hagisawa
Kiyoshi Hamano
Shunshi Kojima
Nobunari Sugio
Mutsuno Suzuki
Yasuyuki Takamatsu
Original Assignee
Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18794392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0303106(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Company, Limited filed Critical Sankyo Company, Limited
Publication of HUP0303106A2 publication Critical patent/HUP0303106A2/hu
Publication of HUP0303106A3 publication Critical patent/HUP0303106A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/58—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/60—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát eljárás képezi pravasztatin vagy e vegyületgyógyászatilag megfelelő sójának elkülönítésére és tisztítására, aholaz eljárás során a pravasztatint vagy ennek analógjait CH3CO2Ráltalános képletű szerves oldószerrel extrahálják, ahol a képletben Rjelentése 3 vagy ennél több szénatomos alkilcsoport. Az extrakcióseljárás kombinálható a szennyezések elbontására szolgáló művelettelis, amelyhez szervetlen savat és/vagy szervetlen bázist alkalmaznak. Atalálmány szerinti eljárás segítségével az (I) képletű vegyületmennyisége 0,1 tömeg%-ra vagy ennél kisebb mennyiségre csökkenthető. Atalálmány tárgyát képezi ezen kívül maga a tisztított termék is, amelylegalább 99,5 %-ban tartalmaz pravasztatin-nátriumot, és ahol aszennyezésként jelenlévő (I) képletű vegyület mennyisége legfeljebb0,1 tömeg%. Ó
HU0303106A 2000-10-16 2001-10-15 Method of purifying pravastatin HUP0303106A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000315256A JP3236282B1 (ja) 2000-10-16 2000-10-16 プラバスタチンを精製する方法
PCT/JP2001/009045 WO2002032848A1 (fr) 2000-10-16 2001-10-15 Procede de purification de pravastatine

Publications (2)

Publication Number Publication Date
HUP0303106A2 true HUP0303106A2 (hu) 2003-12-29
HUP0303106A3 HUP0303106A3 (en) 2004-10-28

Family

ID=18794392

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303106A HUP0303106A3 (en) 2000-10-16 2001-10-15 Method of purifying pravastatin

Country Status (19)

Country Link
US (1) US20030216596A1 (hu)
EP (4) EP1327626A4 (hu)
JP (1) JP3236282B1 (hu)
KR (1) KR20030042018A (hu)
CN (4) CN1868996A (hu)
AU (1) AU2001294258A1 (hu)
BR (1) BR0114681A (hu)
CA (1) CA2425883A1 (hu)
CZ (1) CZ20031052A3 (hu)
HU (1) HUP0303106A3 (hu)
IL (1) IL155360A0 (hu)
MX (1) MXPA03003347A (hu)
NO (1) NO20031739L (hu)
NZ (3) NZ536892A (hu)
PL (1) PL360934A1 (hu)
RU (2) RU2260582C2 (hu)
SK (1) SK4532003A3 (hu)
WO (1) WO2002032848A1 (hu)
ZA (1) ZA200302966B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW589178B (en) * 2003-02-21 2004-06-01 China Chemical & Pharmaceutica A novel industrial process to obtain pravastatin sodium of high purity
EP1452519A1 (en) * 2003-02-25 2004-09-01 Balkanpharma-Razgrad AD Method for the isolation and purification of pravastatin sodium
SG155189A1 (en) * 2004-08-06 2009-09-30 Transform Pharmaceuticals Inc Novel fenofibrate formulations and related methods of treatment
US20090042979A1 (en) * 2004-08-06 2009-02-12 Transform Pharmaceuticals Inc. Novel Statin Pharmaceutical Compositions and Related Methods of Treatment
KR20070038553A (ko) * 2004-08-06 2007-04-10 트렌스폼 파마수티컬스 인코퍼레이티드 신규한 스타틴 약제학적 조성물 및 관련된 치료방법
CN100361954C (zh) * 2005-05-16 2008-01-16 天津市冠东科技有限公司 制备普伐他汀结晶体的干燥方法
JP4813841B2 (ja) * 2005-07-25 2011-11-09 キユーピー株式会社 プラバスタチンナトリウムの製造方法
US8734795B2 (en) * 2008-10-31 2014-05-27 Biogen Idec Ma Inc. Light targeting molecules and uses thereof
CN109796333B (zh) * 2019-01-25 2021-04-09 北大方正集团有限公司 一种从发酵液中提取纯化普伐他汀钠的方法
CN112778120B (zh) * 2019-11-08 2024-05-17 上海现代制药股份有限公司 一种降血脂类药物氧化杂质的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US5202029A (en) * 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
DK0784605T3 (da) * 1995-08-03 2000-07-31 Dsm Nv Selektiv fremgangsmåde til deacyleringen af acylforbindelser
SI20305A (sl) * 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
WO2002030415A1 (en) * 2000-10-05 2002-04-18 Biogal Gyogyszergyar Rt Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same

Also Published As

Publication number Publication date
KR20030042018A (ko) 2003-05-27
MXPA03003347A (es) 2003-06-19
NO20031739D0 (no) 2003-04-15
RU2005113661A (ru) 2006-11-10
WO2002032848A1 (fr) 2002-04-25
NZ536892A (en) 2005-05-27
CN1679535A (zh) 2005-10-12
CN1481353A (zh) 2004-03-10
CZ20031052A3 (cs) 2003-09-17
HUP0303106A3 (en) 2004-10-28
ZA200302966B (en) 2004-07-15
US20030216596A1 (en) 2003-11-20
EP1327626A1 (en) 2003-07-16
PL360934A1 (en) 2004-09-20
CN1868996A (zh) 2006-11-29
SK4532003A3 (en) 2003-10-07
NZ536891A (en) 2005-05-27
IL155360A0 (en) 2003-11-23
NO20031739L (no) 2003-06-13
JP3236282B1 (ja) 2001-12-10
RU2260582C2 (ru) 2005-09-20
JP2002121174A (ja) 2002-04-23
NZ525256A (en) 2005-01-28
EP1327626A4 (en) 2004-08-18
CN1690037A (zh) 2005-11-02
EP1514863A1 (en) 2005-03-16
BR0114681A (pt) 2003-12-09
EP1522589A1 (en) 2005-04-13
AU2001294258A1 (en) 2002-04-29
CA2425883A1 (en) 2003-04-15
EP1514862A1 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
EP1462447A3 (en) Method for the preparation of pure citalopram
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
KR960037682A (ko) 축합 6환 화합물 및 그의 제조방법
SE0200730L (sv) Kristallin bas av citalopram
AU2003214132A1 (en) (meth)acrylic acid crystal and method for the production and purification of aqueous (meth)acrylic acid
CA2155541A1 (en) Process to Improve Alkyl Ester Sulfonate Surfactant Compositions
EA200200016A1 (ru) Способ получения чистого циталопрама
HUP0303106A2 (hu) Eljárás pravasztatin tisztítására
ES2239937T1 (es) Procedimiento para la recuperacion de compuestos de estanina a partir de un caldo de fermentacion.
JP2004510817A5 (hu)
ATE323777T1 (de) Verfahren zur herstellung von lysophosphatidyl- ethanolamin
AU2003258335A1 (en) A method for the purification of lansoprazole
RU2003110580A (ru) Способ очистки правастатина
JP2004521875A5 (hu)
AR037005A1 (es) Derivados de acidos dimetilfenilaceticos, derivados de piperidina, y proceso para la produccion de derivados de piperidina.
KR860001048A (ko) 플루오로알릴아민 유도체의 제조방법
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
AU5956796A (en) Process and compositions for the recovery of ascorbic acid
HUP0202604A2 (en) Method for purifying carbonic acid chlorides
BR9713307A (pt) Processo para recuperar ácido ascórbico de uma ali ascóbico.
MY135836A (en) Process for the production and purification of n-butyl acrylate
TWI262913B (en) Manufacturing method of diene compound
ATE258158T1 (de) Verfahren zum reinigen von milchsäureestern
TW200519090A (en) Process for producing high purity 3, 5-dihydroxy-6-heptenoic acid derivative
AU2001283166A1 (en) Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees